The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Cyclodextrin-based pharmaceutics: past, present and future
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Comprehensive supramolecular chemistry
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5097 · Cited by 6,476
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Self-citationCyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development
Szente, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00092-1 · Cited by 540
Cyclodextrin-based controlled drug release system
Hirayama, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00058-1 · Cited by 494
Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells
Thomas, M., & Klibanov, A. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192581499 · Cited by 483
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
CyclodextrinsEnabling Excipients: Their Present and Future Use in Pharmaceuticals
Thompson, D. O. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i1.10 · Cited by 421
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Self-citationMedicinal Applications of Cyclodextrins
Szejtli, J. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140304 · Cited by 347
In Vitro Gene Delivery to Hepatocytes with Galactosylated Polyethylenimine
Zanta, M.-A., Boussif, O., Adib, A., & Behr, J.-P. (1997) · Bioconjugate Chemistry · doi:10.1021/bc970098f · Cited by 339
New Class of Polymers for the Delivery of Macromolecular Therapeutics
Gonzalez, H., Hwang, S. J., & Davis, M. E. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990072j · Cited by 312
Self-citationVerreck, G., Chun, I., Peeters, J., Rosenblatt, J., & Brewster, M. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1023450006281 · Cited by 311
Self-citationCyclodextrins in drug carrier systems.
Uekama, K., & Otagiri, M. (1987) · PubMed · Cited by 300
Cyclodextrins in peptide and protein delivery
Irie, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00057-x · Cited by 298
Cyclodextrin-Modified Polyethylenimine Polymers for Gene Delivery
Pun, S. H., Bellocq, N. C., Liu, A., Jensen, G., Machemer, T., Quijano, E., Schluep, T., Wen, S., Engler, H., Heidel, J., et al. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049891g · Cited by 297
Self-citationRole of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Self-citationDe Beule, K., & Van Gestel, J. (2001) · Drugs · doi:10.2165/00003495-200161001-00003 · Cited by 283
Peeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Self-citationPartial Acetylation of Polyethylenimine Enhances In Vitro Gene Delivery
Forrest, M. L., Meister, G. E., Koerber, J. T., & Pack, D. W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016251.42392.1e · Cited by 247
Artificial Chaperones: Protein Refolding via Sequential Use of Detergent and Cyclodextrin
Rozema, D., & Gellman, S. H. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00113a036 · Cited by 237
Willems, L., van der Geest, R., & de Beule, K. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00338.x · Cited by 227
Development of a Nonviral Gene Delivery Vehicle for Systemic Application
Pun, S. H., & Davis, M. E. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0155768 · Cited by 223
Self-citationArima, H., Kihara, F., Hirayama, F., & Uekama, K. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000111n · Cited by 222
Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery
Hwang, S. J., Bellocq, N. C., & Davis, M. E. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001084 · Cited by 217
Self-citationJeu, L., Piacenti, F. J., Lyakhovetskiy, A. G., & Fung, H. B. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80126-1 · Cited by 213
Graham, D. R. M., Chertova, E., Hilburn, J. M., Arthur, L. O., & Hildreth, J. E. K. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8237-8248.2003 · Cited by 208
Rozema, D., & Gellman, S. H. (1996) · Biochemistry · doi:10.1021/bi961638j · Cited by 207
Cyclodextrin nephrosis in the rat.
Frank, D. W., Gray, J. E., & Weaver, R. N. (1976) · PubMed · Cited by 204
Synthesis of Linear, β-Cyclodextrin-Based Polymers and Their Camptothecin Conjugates
Cheng, J., Khin, K. T., Jensen, G. S., Liu, A., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340924 · Cited by 203
Self-citationPun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201
Self-citationArtificial Chaperone-assisted Refolding of Carbonic Anhydrase B
Rozema, D., & Gellman, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3478 · Cited by 199
Liao, Z., Graham, D. R., & Hildreth, J. E. K. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203322280900 · Cited by 185
RAJPURKAR, A., & DHABUWALA, C. B. (2003) · Journal of Urology · doi:10.1097/01.ju.0000072524.82345.6d · Cited by 181
Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F., & Uekama, K. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025613a · Cited by 161
Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs
Brewster, M. E., Hora, M., Simpkins, J. W., & Bodor, N. S. (1991) · Pharmaceutical Research · doi:10.1023/a:1015870521744 · Cited by 156
Self-citationZia, V., Rajewski, R. A., & Stella, V. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011041628797 · Cited by 149
Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety
Purkins, L., Wood, N., Greenhalgh, K., Allen, M. J., & Oliver, S. D. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01993.x · Cited by 149
Davis, M. E., Pun, S., Bellocq, N. C., Reineke, T. M., Popielarski, S. R., Mishra, S., & Heidel, J. D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456179 · Cited by 145
Self-citationKihara, F., Arima, H., Tsutsumi, T., Hirayama, F., & Uekama, K. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025557d · Cited by 143
Drug carrier systems based on water-soluble cationic $beta;-cyclodextrin polymers
Li, J., Xiao, H., Li, J., & Zhong, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.026 · Cited by 140
A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease
Yue, I. C., Poff, J., Cortés, M. E., Sinisterra, R. D., Faris, C. B., Hildgen, P., Langer, R., & Shastri, V. P. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.113 · Cited by 132
Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole
Jaruratanasirikul, S., & Kleepkaew, A. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050280 · Cited by 128
Shabsigh, R., Padma-Nathan, H., Gittleman, M. C., McMurray, J., Kaufman, J. M., & Goldstein, I. (2000) · Urology · doi:10.1016/s0090-4295(99)00442-2 · Cited by 126
Charman, S. A., Mason, K. L., & Charman, W. N. (1993) · Pharmaceutical Research · doi:10.1023/a:1018994102218 · Cited by 124
Antitumor Activity of β-Cyclodextrin Polymer−Camptothecin Conjugates
Cheng, J., Khin, K. T., & Davis, M. E. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049966y · Cited by 123
Self-citationCyclodextrins and the Biopharmaceutics Classification System of Drugs
Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023088423667 · Cited by 121
Reineke, T. M., & Davis, M. E. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025592k · Cited by 119
Self-citationThe pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent
Purkins, L., Wood, N., Greenhalgh, K., Eve, M. D., Oliver, S. D., & Nichols, D. J. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01992.x · Cited by 117
Use and Benefits of Nonsteroidal Anti-inflammatory Drugs
Brooks, P. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00204-0 · Cited by 116
Popielarski, S. R., Mishra, S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034010b · Cited by 107
Self-citationNew Organic Nanoporous Polymers and Their Inclusion Complexes
Ma, M., & Li, D. (1999) · Chemistry of Materials · doi:10.1021/cm981090y · Cited by 102
Structural Effects of Carbohydrate-Containing Polycations on Gene Delivery. 2. Charge Center Type
Reineke, T. M., & Davis, M. E. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025593c · Cited by 98
Self-citationItraconazole: pharmacology, clinical experience and future development
De Beule, K. (1996) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(95)00043-7 · Cited by 96
Piérard, G. E., Arrese, J. E., & Piérard-Franchimont, C. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.2.287 · Cited by 92
The potential use of cyclodextrins in parenteral formulations.
Brewster, M. E., Simpkins, J. W., Hora, M., et al. (1989) · PubMed · Cited by 91
Self-citationStudd, J. W. W., Pornel, B., Márton, I., Bringer, J., Varin, C., Tsouderos, Y., & Christiansen, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06196-0 · Cited by 91
The BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Alterations in Gastric Acidity in Patients Infected with Human Immunodeficiency Virus
Welage, L. S., Carver, P. L., Revankar, S. G., Pierson, C. L., & Kauffman, C. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1431 · Cited by 86
Inclusion of Aromatic Compounds by a β-Cyclodextrin–Epichlorohydrin Polymer
Harada, A., Furue, M., & Nozakura, S. (1981) · Polymer Journal · doi:10.1295/polymj.13.777 · Cited by 84
Shabsigh, R., Padma-Nathan, H., Gittleman, M. C., McMurray, J., Kaufman, J. M., & Goldstein, I. (2000) · Urology · doi:10.1016/s0090-4295(99)00612-3 · Cited by 81
Inclusion complexation of ziprasidone mesylate with β-cyclodextrin sulfobutyl ether
Kim, Y., Oksanen, D. A., Massefski, W. W., Blake, J. F., Duffy, E. M., & Chrunyk, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980109t · Cited by 80
Molecularly imprinted polymer of β-cyclodextrin for the efficient recognition of cholesterol
Asanuma, H., Kakazu, M., Shibata, M., & Hishiya, T. (1997) · Chemical Communications · doi:10.1039/a704176d · Cited by 78
Use of Cyclodextrin and Its Derivatives as Carriers for Oligonucleotide Delivery
Zhao, Q., Temsamani, J., & Agrawal, S. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.185 · Cited by 76
Selective disruption of protein aggregation by cyclodextrin dimers
Leung, D. K.-W., Yang, Z., & Breslow, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5050 · Cited by 72
Lu, J., Hill, M., Hood, M., Greeson, D. F., Horton, J. R., Orndorff, P. E., Herndon, A. S., & Tonelli, A. E. (2001) · Journal of Applied Polymer Science · doi:10.1002/app.1852 · Cited by 71
Cyclodextrins in oligonucleotide delivery
Redenti, E., Pietra, C., Gerloczy, A., & Szente, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00230-7 · Cited by 71
Henzl, M. R., & Loomba, P. K. (2003) · PubMed · Cited by 58
Brewster, M. E., Verreck, G., Chun, I., et al. (2004) · PubMed · Cited by 48
Self-citationNovel synthesis of a water-soluble cyclodextrin-polymer having a chitosan skeleton
Tanida, F., Tojima, T., Han, S.-M., Nishi, N., Tokura, S., Sakairi, N., Seino, H., & Hamada, K. (1998) · Polymer · doi:10.1016/s0032-3861(97)10206-3 · Cited by 42
Buvat, J., Costa, P., Morlier, D., Lecocq, B., Stegmann, B. J., & Albrecht, D. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)64030-8 · Cited by 40
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Itraconazole: pharmacokinetics and indications.
Negroni, R., & Arechavala, A. I. (1993) · PubMed · Cited by 38
Huang, L., Taylor, H., Gerber, M., Orndorff, P. E., Horton, J. R., & Tonelli, A. E. (1999) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19991024)74:4<937::aid-app20>3.0.co;2-k · Cited by 31
Endometrial safety and tolerability of AERODIOL® (intranasal estradiol) for 1 year
Gompel, A., Bergeron, C., Jondet, M., Dhont, M. A., van der Mooren, M. J., Tóth, K., Panay, N., & von Holst, T. (2000) · Maturitas · doi:10.1016/s0378-5122(00)00144-4 · Cited by 29
Daoud-Mahammed, S., Couvreur, P., Amiel, C., Besnard, M., Appel, M., & Gref, R. (2004) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(04)50005-9 · Cited by 23
Santucci, L., Fiorucci, S., Chiucchi�, S., et al. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308075 · Cited by 21
Controlling the Behaviors of Biodegradable/Bioabsorbable Polymers with Cyclodextrins
Rusa, C. C., Shuai, X., Shin, I. D., Bullions, T. A., Wei, M., Porbeni, F. E., Lu, J., Huang, L., Fox, J. D., & Tonelli, A. E. (2004) · Journal of Polymers and the Environment · doi:10.1023/b:jooe.0000038547.36750.78 · Cited by 21
Goldstein, I., Auerbach, S., Padma-Nathan, H., Rajfer, J., Fitch, W. P., Schmitt, L., & and the Alprostadil Alfadex Study Group (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900543 · Cited by 20
Yamamoto, M., Ohira, A., Honda, O., Sato, N., Furuke, K., Yodoi, J., & Honda, Y. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500109 · Cited by 19
Wełnicka-Jaśkiewicz, M., & Jassem, J. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00067-7 · Cited by 16
Effect of hormone replacement therapy on cardiovascular disease: current opinion
Khan, N. S., & Malhotra, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.667 · Cited by 15
Therapeutic value and long-term safety of pulsed estrogen therapy
Dören, M., Azzawi, F. A., Donnez, J., van der Mooren, M. J., Villero, J., & Gompel, A. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00201-8 · Cited by 11
Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
Serni, U. (1993) · PubMed · Cited by 9
Cited by
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Self-citationOvercoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Webber, M. J., Appel, E. A., Meijer, E. W., & Langer, R. (2016) · Nature Materials · doi:10.1038/nmat4474 · Cited by 1,605
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Metadata
- Authors
- Davis, M. E., & Brewster, M. E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-12
- Volume
- 3
- Issue
- 12
- Pages
- 1023-1035
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2044609602
- Cited by
- 1,996
- References
- 93
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.